Zogenix (ZGNX) BidaskScore is lowered to Sold

Zogenix

The BidaskScore of Zogenix ZGNXZGNX shows that the shares of the company are now ZGNXStrongly Bought Sold by investors.

The BidaskScore of the PharmaceuticalsPharmaceuticals shows that the sector is PharmaceuticalsStrongly Bought Strongly Sold since April 16.

Here are the BidAskScore of other related companies in the Pharmaceuticals sector:

Zogenixˌ Inc. is a pharmaceutical companyˌ which engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. It develops two products candidate: ZX008 and Relday. The company was founded by Stephen J. Farrˌ Cam L. Garnerˌ Roger L. Hawleyˌ Bret E. Megargelˌ Jonathan M. N. Rigbyˌ Scott L. Glennˌ and John J. Turanin on May 11ˌ 2006 and is headquartered in Emeryvilleˌ CA.

Zogenix

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.